Latest TB Research Publications

8 October 2024

Latest open access and non-open access TB research publications compiled from various sources.

***********

Effectiveness and safety of modified fully oral 9-month treatment regimens for rifampicin-resistant tuberculosis: a prospective cohort study
The Lancet Infectious Diseases
October 2024 /open access/

— Accompanying comment: Longevity of modified standard short treatment regimens for rifampicin-resistant tuberculosis
/open access/

***********

Targeted next-generation sequencing to diagnose drug-resistant tuberculosis: a systematic review and meta-analysis
The Lancet Infectious Diseases
October 2024 /open access/

***********

Efficacy and safety of shorter multidrug-resistant or rifampicin-resistant tuberculosis regimens: a network meta-analysis
BMC Infectious Diseases
1 October 2024 /open access/

***********

Bedaquiline versus injectable containing regimens for rifampicin-resistant and multidrug-resistant tuberculosis in a reference center in Brazil – a real-world evidence study using a retrospective design
BMC Infectious Diseases
7 October 2024 /open access/

***********

Further analysis of tuberculosis in eight high-burden countries based on the Global Burden of Disease Study 2021 data
Infectious Diseases of Poverty
30 September 2024 /open access/

***********

RESIST-TB October 2024 newsletter

RESIST-TB October 2024 newsletter with the latest updates and research publications on drug-resistant TB.
/open access and non-open access/

***********

IJTLD October 2024 issue

The International Journal of Tuberculosis and Lung Disease (IJTLD) is the official publication of the International Union Against Tuberculosis and Lung Disease (The Union). The Journal presents clinical research and epidemiological studies on lung health, including articles on TB, TB-HIV and respiratory diseases such as COVID-19, asthma, COPD, child lung health and the hazards of tobacco and air pollution.
/non-open access/

***********